Systemic Disease
Visual System May Serve as Ideal Model for MS Drug Assessment
The neurodegenerative disease can be difficult to track in terms of remyelination, but certain agents can be monitored through ocular imaging to gauge efficacy.
04/26/2024
Statins Decrease Graves’ Ophthalmopathy Risk
Reduction by 80% was found in one Taiwanese study.
04/10/2024
Having Both DR and Uveitis Linked to Poorer Visual Outcomes
Late-stage neovascular complications and inflammatory sequelae are much more common in these eyes.
03/11/2024
Rheumatoid Arthritis Causes Greater Cataract, Glaucoma Risk
Recent research determined the relationship exists in this direction only—the ocular conditions don’t affect chances of developing this autoimmune disease.
03/07/2024
Cholesterol Medications Increase Glaucoma Risk
Patients on this regimen may require screening for the disease.
01/02/2024
Polycystic Ovary Syndrome Common Among IIH Patients
Despite this association, the condition was not found to influence long-term vision or headache prognosis.
12/26/2023
Vision Screenings Needed for Parkinson’s Disease
Active evaluation of visual function in these individuals is key to provide the best occupational therapy.
12/14/2023
GCIPL Thickness Declines in Chronic Kidney Disease
Poor renal function was associated with thinning, particularly in participants with diabetes and hypertension.
10/12/2023
TED Patients Improved, Ocular Alignment Stable on Teprotumumab
Baseline measures such as clinical activity score and right and left gaze horizontal prism deviation can help better predict how patients respond to this treatment.
09/26/2023
Certain Macular Regions Indicative of MS Progression
The retinal nerve fiber and ganglion cell layers are both important in early detection of the disease.
07/19/2023
Upcoming Events
May 2, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Kamran Riaz, MD, and Melissa Barnett, OD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
May 17-19, 2024
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
